Femoston 2/10 Tablets (Estradiol Hemihydrate, Didrogesterone)

Adult dose

1. Initial dose - If the patient is still menstruating, it is advisable to start taking the medication within at least 5 days from the start of menstruation. - For patients who have not menstruated for more than 12 months, the medication can be started at any time, regardless of menstruation. - During the first 14 days of the 28-day cycle, take 1 tablet containing 2 mg of estradiol once daily. In the following 14 days, take 1 tablet containing 2 mg of estradiol and 10 mg of didrogesterone once daily.

This medication should not be used by children under 18 years of age, pregnant women, or women who may become pregnant, and nursing mothers. It should not be administered to patients with suspected or confirmed breast cancer or tumors responsive to estrogen or progestogen, as well as those with undiagnosed abnormal genital bleeding. Caution should be used in patients with a history of thrombosis or those at high risk of thrombosis, patients with poor liver function, those with cerebrovascular disease, or those with a predisposition to thrombosis. This medication contains lactose, so patients with lactose intolerance or genetic sugar absorption disorders should not take it. While taking this medication, symptoms such as headache, abdominal pain, breast pain, dyspepsia, skin rash, elevated blood pressure, and menstrual disorders may occur, and if such symptoms appear, consultation with a doctor is necessary. This medication may increase the risk of breast cancer and endometrial cancer, so regular breast examinations and endometrial tests are required. There may be an increased risk of cardiovascular diseases such as thrombosis, heart attack, and stroke, so patients with a history of heart disease must consult with their doctor. There may be interactions with other medications, so patients should inform their doctor or pharmacist of any other medications they are taking. It should not be used during pregnancy, and if pregnancy is confirmed during treatment, it should be immediately discontinued and a doctor should be informed. In cases of overdose, symptoms such as nausea, vomiting, dizziness, and breast tenderness may occur, and in such cases, medical attention should be sought immediately. It is important to have regular check-ups with a doctor during treatment and consult immediately if unusual symptoms occur.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in mucous membranes of mouth/eyes, difficulty breathing or shortness of breath, asthma attacks, respiratory abnormalities accompanying cough and fever, yellowing of skin or eyes (jaundice), severe lethargy, sudden and very severe headache, thunderclap headache, seizures, confusion, visual abnormalities, paralysis, urination

Mild side effects

Headache, abdominal pain, breast pain, breast tenderness, back pain, nausea, vomiting, abdominal distension, dyspepsia, migraine, depression, irritability, dizziness, changes in libido, gallbladder disorders, liver function changes, breast enlargement, skin allergic reactions (rash, hives, itching), vascular swelling, skin purpura, vaginal candidiasis, menstrual disturbances, pelvic pain, changes in discharge, symptoms resembling premenstrual syndrome, symptoms resembling cystitis, hypertension, peripheral vascular disorders,

This medication should be stored in an airtight container that allows good air circulation, and it is recommended to store it at room temperature between 1 to 30 degrees Celsius. Storing it this way helps maintain the effectiveness of the medication for a long time.

Appearance

Pink tablet: A pink round, biconvex film-coated tablet Yellow tablet: A yellow round, biconvex film-coated tablet

Package unit

28 tablets/PTP